Tilray Brands (TLRY) Shares Outstanding (2017 - 2026)
Tilray Brands (TLRY) posted Shares Outstanding (Entity) of $116.5 million for Q1 2026, little changed on a QoQ basis from $116.5 million in Q4 2025, and up 18.52% year-over-year from $98.3 million in Q1 2025.
Tilray Brands (TLRY) Shares Outstanding (2017 - 2026) Analysis & Trends
Tilray Brands' Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $116.5 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 18.52% year-over-year to $116.5 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $116.5 million (up 18.52% YoY) and the FY2025 annual result came in at $106.1 million, up 27.5% from the prior year.
- Shares Outstanding (Entity) was $116.5 million for Q1 2026 at Tilray Brands, roughly flat from $116.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $116.5 million in Q1 2026 and bottomed at $49.8 million in Q1 2022.
- A 5-year average of $81.6 million and a median of $77.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 97.62% — and 2026, when it rose 18.52%.
- Tilray Brands' Shares Outstanding (Entity) stood at $61.3 million in 2022, then grew by 19.53% to $73.3 million in 2023, then rose by 26.79% to $92.9 million in 2024, then advanced by 25.39% to $116.5 million in 2025, then grew by 0.02% to $116.5 million in 2026.
- Business Quant data shows TLRY's Shares Outstanding (Entity) at $116.5 million in Q1 2026, $116.5 million in Q4 2025, and $111.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 112.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 112.68 Mn |
| Nov 30, 2025 | 110.34 Mn |
| Aug 31, 2025 | 106.03 Mn |
| May 31, 2025 | 89.03 Mn |
| Feb 28, 2025 | 90.83 Mn |
| Nov 30, 2024 | 86.50 Mn |
| Aug 31, 2024 | 87.54 Mn |
| May 31, 2024 | 74.26 Mn |
| Feb 29, 2024 | 75.44 Mn |
| Nov 30, 2023 | 73.08 Mn |
| Aug 31, 2023 | 69.12 Mn |
| May 31, 2023 | 61.80 Mn |
| Feb 28, 2023 | 61.55 Mn |
| Nov 30, 2022 | 61.17 Mn |
| Aug 31, 2022 | 57.53 Mn |
| May 31, 2022 | 48.12 Mn |
| Feb 28, 2022 | 48.57 Mn |
| Nov 30, 2021 | 46.03 Mn |
| Aug 31, 2021 | 44.94 Mn |
| May 31, 2021 | 26.95 Mn |